Risk factors for biliary tract carcinogenesis

Annals of Oncology

Volumn 10, Issue SUPPL. 4, 1999, Pages

  Chapman, R W ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Biliary tract; Carcinogenesis; Cholangiocarcinoma; Risk factors

Indexed keywords

BILE DUCT CARCINOMA; BILIARY TRACT CANCER; CANCER RISK; CARCINOGENESIS; CAROLI DISEASE; CLONORCHIS SINENSIS; COMMON BILE DUCT CYST; CONFERENCE PAPER; DISEASE ASSOCIATION; FASCIOLA HEPATICA; HEPATITIS C; HUMAN; OPISTHORCHIS VIVERRINI; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

EID: 0032807706     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_4.S308     Document Type: Conference Paper

References (31)

1. Chapman RWG, Arborgh B, Rhodes JM et al. Primary sclerosing cholangitis: A review of its clinical features, cholangiography and hepatic histology; Gut 1980;21:870-7
2. Weisner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis; Gastroenterology 1980; 79:200-6
3. Mir-Madjlessi SH, Farmer RG, Sivak MV. Bile duct carcinoma in patients with ulcerative colitis; Dig Dis Sci 1987; 32:145-54
4. Rosen CB, Nagorney DM, Wiesner RH et al. Cholangiocarcinoma complicating primary sclerosing cholangitis; Ann Surg 1991; 213:21-5
5. Aadland E, Schrumpf E, Fausa O et al. Primary sclerosing cholangitis: A long-term follow-up; Scand J Gastroenterol 1987;22:655-64
6. Broome U, Olsson R, Loof L et al. Natural history & prognostic factors in 305 Swedish patients with primary sclerosing cholangitis; Gut 1996;38:610-15
7. Nicholas JC, Gores GJ, LaRusso NF et al. Diagnostic value of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis; Mayo Clin Proc 1993;68:874-9
8. Bergquist A, Glaumann H, Broome U. Smoking, cholangiocarcinoma and primary sclerosing cholangitis; Hepatology, 1998;28:A, 1079
9. Broome U, Lofberg R, Veress B et al. Primary sclerosing cholangiis & ulerative colitis: evidence for increased neoplastic potential; Hepatology 1995;22:1404-8
10. Martins EBG, Fleming KA, Garrido MC et al. Superficial thrombophlebitis, dysplasia & cholangiocarcinoma in primary sclerosing cholangitis; Gastroenterology 1994;107:537-42
11. Fleming KA, Clausen OP, Glaumann H et al. Biliary dysplasia indicating risk of development of cholangiocarcinoma in primary sclerosing cholangitis; Hepatology, 1998 A
12. Taylor ACF, Palmer KR. Caroli'sdisease; Euro J Gastroenterol Hepatol 1998;10:105-8
13. Caroli J, Couihand C. Une affection nouvelle, sans doute congenitale, des voies biliares; la dilatation kystique amlobave des canaux hepatiques; Sem Hop Paris 1958;14:496-502
14. Barros JL, Polo JR, Sanaba J. Congenital cystic dilatation of the intrahepatic bile ducts (Caroli's disease) report of a case and review of the literature; Surgery 1979;85:589-92
15. Dayton MT, Longmire WP, Tompkins RK. Caroli's disease a premalignant condition?; Am J Surg 1983;145:41-8
16. Boyle MJ, Doyle GD, McNulky JG. Monolabar Caroli's disease; Am J Gastroenterol 1989; 84:1437-44
17. Phinney PR, Austin GE, Kadell BM. Cholangiocarcinoma arising in Caroli's disease; Arch Pathol Lab Med 1981;105:194-7
18. Fozard JBJ, Wyatt JI, Hall RI. Epithelial dysplasia in Caroli's disease; Gut 1989;30:1150-3
19. Lipsett PA, Pitt HA, Colombani RM et al. Choledochal cyst disease. A changing pattern of presentation: Ann Surg 1994; 220:644-52
20. Voyles CR, Smadja C, Shonds C et al. Carcinoma in choledochal cysts: age-related incidence; Arch Surg 1983;118:986-8
21. Schwartz DA. Cholangiocarcinoma associated with liver fluke infection; A preventable source of morbidity in Asian immigrants; Am J Gastroenterol 1986; 81:76-9
22. Sithithaworn P, Haswell-Elkins M, Mairiang P. Parasite-associated morbidity; liver fluke infection & bile duct cancer in northeast Thailand; Int J Parasitol 1994;24:833-43
23. Sithithaworn P, Tesana S, Pipitgool V et al. Quantitative postmorten study of Opisthorchis viverrini in man in northeast Thailand; Trans R Soc Trop Med Hyg 1991;85:765-8
24. Pungpak S, Harinasuta T, Bunnag D et al. Faecal egg output in relation to worm burden & clinical features in human opisthorchiasis; Southeast Asian JH Trop Med Public Health 1990;21:275-80
25. Elkins DB, Mairiang E, Sithithaworn P et al. Cross-sectional patterns of hepatobiliary abnormalities & possible precursor conditions of cholangiocarcinoma associated with Opisthorchis viverrini infection in humans; Am J Trop Med Hyg 1996;55:295-301
26. Haswell-Elkins MR, Mairiang E, Mairiang P et al. Cross-sectional sudy of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand; Int J Cancer 1994;59:505-9
27. Mairiang E, Haswell-Elkins MR, Mairiang P et al. Reversal of biliary tract abnormalities associated with Opisthorchis viverrini infection following praziquantel treatment; Trans R Soc Trop Med Hyg 1993;87:194-7
28. Leung JWC, Sung Y, Banez VP et al. Endoscopic cholangiopancreatography in hepatic clonorchiasis - a follow-up study; Gastrointest Endosc 1990;36:360-3
29. Satarug S, Lang MA, Yongvanit P et al. Induction of cytochrome P450 2A6 expression in humans by the carcinogenic parasite infection, opisthorchiasis viverrini; Cancer Epidemiol Biomarkers Prev 1996;5:795-800
30. Lee J_H, Rim H_J, Bak U_B. Effect of clonorchis sinensis infection and dimethylnitrosamine administration on the induction of cholangiocarcinoma in Syrian golden hamsters; Korean J Parasitol 1993;31:21-30
31. Watanapa P. Cholangiocarcinoma in patients with opisthorchiasis; Br J Surg 1996;83:1062-4